InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
T+90 hit rate
75%
T+90 mean return
+5.8%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by C.P. Riedl. Director active across 1 company, notably Vivoryon Therapeutics N.V.. Cumulatively, 4 reports have been published. Activity tracked since 22 June 2022. The latest transaction was disclosed on 30 June 2025 (Purchase). Regulator: AFM. All data is accessible without signup.
Declarations4 total
25,000 shares0OptieAFM:176908
Ideal exit: 27 Mar 2026 (T+270)
25,000 shares0OptieAFM:160247
Ideal exit: 18 Mar 2025 (T+270)
90,000 shares0OptieAFM:144123
Ideal exit: 19 Mar 2023 (T+270)
1,000 shares0Gewoon aandeelAFM:145240
Ideal exit: 19 Mar 2023 (T+270)
4 of 4 declarations
